 Bristol-Myers Squibb Co. and partner Ono Pharmaceutical Co. have sued Merck & Co., alleging that its new cancer drug violates their patent for a method of harnessing the body's immune system to fight cancer.. Bristol and Ono filed suit in federal court in Delaware on Thursday, the same day that Merck received U.S. Food and Drug Administrationapproval to market Keytruda as a treatment for the deadly skin cancer melanoma.. The...
  